Barber EL - Search Results

1

In the patient's shoes: The impact of hospital proximity and volume on stage I endometrial cancer care patterns and outcomes.

Wang CC, Bharadwa S, Domenech I, Barber EL. Wang CC, et al. Among authors: barber el. Gynecol Oncol. 2024 Mar;182:91-98. doi: 10.1016/j.ygyno.2024.01.003. Epub 2024 Jan 22. Gynecol Oncol. 2024. PMID: 38262244

2

The significance of perineural invasion in early-stage cervical cancer.

Elsahwi KS, Barber E, Illuzzi J, Buza N, Ratner E, Silasi DA, Santin AD, Azodi M, Schwartz PE, Rutherford TJ. Elsahwi KS, et al. Gynecol Oncol. 2011 Dec;123(3):561-4. doi: 10.1016/j.ygyno.2011.08.028. Epub 2011 Oct 2. Gynecol Oncol. 2011. PMID: 21968340

3

The combination of intravenous bevacizumab and metronomic oral cyclophosphamide is an effective regimen for platinum-resistant recurrent ovarian cancer.

Barber EL, Zsiros E, Lurain JR, Rademaker A, Schink JC, Neubauer NL. Barber EL, et al. J Gynecol Oncol. 2013 Jul;24(3):258-64. doi: 10.3802/jgo.2013.24.3.258. Epub 2013 Jul 4. J Gynecol Oncol. 2013. PMID: 23875076 Free PMC article.

4

Doll KM, Barber EL, Bensen JT, Snavely AC, Gehrig PA. Doll KM, et al. Among authors: barber el. Gynecol Oncol. 2016 May;141(2):329-335. doi: 10.1016/j.ygyno.2016.03.003. Epub 2016 Mar 18. Gynecol Oncol. 2016. PMID: 26957479 Free PMC article.

5

Who presents satisfied? Non-modifiable factors associated with patient satisfaction among gynecologic oncology clinic patients.

Barber EL, Bensen JT, Snavely AC, Gehrig PA, Doll KM. Barber EL, et al. Gynecol Oncol. 2016 Aug;142(2):299-303. doi: 10.1016/j.ygyno.2016.06.009. Epub 2016 Jun 11. Gynecol Oncol. 2016. PMID: 27287508 Free PMC article.

6

Variation in neoadjuvant chemotherapy utilization for epithelial ovarian cancer at high volume hospitals in the United States and associated survival.

Barber EL, Dusetzina SB, Stitzenberg KB, Rossi EC, Gehrig PA, Boggess JF, Garrett JM. Barber EL, et al. Gynecol Oncol. 2017 Jun;145(3):500-507. doi: 10.1016/j.ygyno.2017.03.014. Epub 2017 Mar 31. Gynecol Oncol. 2017. PMID: 28366545 Free PMC article.

7

Hospital readmission after ovarian cancer surgery: Are we measuring surgical quality?

Barber EL, Doll KM, Gehrig PA. Barber EL, et al. Gynecol Oncol. 2017 Aug;146(2):368-372. doi: 10.1016/j.ygyno.2017.05.012. Epub 2017 May 16. Gynecol Oncol. 2017. PMID: 28522108 Free PMC article.

8

Surgical readmission and survival in women with ovarian cancer: Are short-term quality metrics incentivizing decreased long-term survival?

Barber EL, Rossi EC, Gehrig PA. Barber EL, et al. Gynecol Oncol. 2017 Dec;147(3):607-611. doi: 10.1016/j.ygyno.2017.09.016. Epub 2017 Sep 21. Gynecol Oncol. 2017. PMID: 28941658 Free PMC article.

9

Cost effectiveness of neoadjuvant chemotherapy followed by interval cytoreductive surgery versus primary cytoreductive surgery for patients with advanced stage ovarian cancer during the initial treatment phase.

Tran AQ, Erim DO, Sullivan SA, Cole AL, Barber EL, Kim KH, Gehrig PA, Wheeler SB. Tran AQ, et al. Among authors: barber el. Gynecol Oncol. 2018 Feb;148(2):329-335. doi: 10.1016/j.ygyno.2017.12.015. Epub 2017 Dec 19. Gynecol Oncol. 2018. PMID: 29273308 Free PMC article.

10

Benign hysterectomy performed by gynecologic oncologists: Is selection bias altering our ability to measure surgical quality?

Barber EL, Rossi EC, Alexander A, Bilimoria K, Simon MA. Barber EL, et al. Gynecol Oncol. 2018 Oct;151(1):141-144. doi: 10.1016/j.ygyno.2018.08.010. Epub 2018 Aug 16. Gynecol Oncol. 2018. PMID: 30121133

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

87 results

Search Page

Filters